Adial Pharmaceuticals Plans to Enter Genetic Testing Market Following Allowance of U.S. Patent for Genetic Diagnostic Test Jun 22, 2021
Adial Pharmaceuticals Comments on Article in ‘The Atlantic,’ Highlighting the Second Pandemic of Addiction Jun 7, 2021
Adial Announces Funding of Management-Led $2,100,000 Above Market Private Placement at $3.00 Per Share Jun 3, 2021
Adial Pharmaceuticals Featured on Multiple News Broadcasts Nationwide Regarding the Second Pandemic of Alcohol Use Disorder May 18, 2021
